An investigator into the study of Alzheimer’s disease for almost three decades, Golde has published more than 220 papers that have been cited more than 25,000 times.He has expanded his leading-edge research to include other neurodegenerative diseases, cancer and even malaria.Nationally, he is a member of the medical and scientific advisory board for the Alzheimer’s Association and the BrightFocus Foundation.
Events - Primer's event detection algorithm clusters and summarizes multiple documents describing real-world events.
Mentions - Mentions are snippets of text that map to a person.
Docs - The number of documents that match to a person in Primer's corpus of news articles.
Full tech explainer here.
To update Wikipedia with this information, visit the page for the subject above.
the University of Florida
Researchers say stress triggers the release of a hormone that boosts production of a protein in the brain that is involved in the development of Alzheimer's. In a study published in The EMBO Journal, Dr. Todd Golde, director of the Center for Translational Research in Neurodegenerative Disease at the University of Florida, and colleagues describe how a hormone released by the brain in response to stress increases production of a protein associated with Alzheimer's development. Based on their findings, the team is now investigating a novel Alzheimer's prevention strategy: the use of an antibody that blocks the release of this stress hormone, inhibiting the production of the Alzheimer's-related protein. For their study, Dr. Golde and colleagues set out to gain a better understanding of the mechanisms that link stress and Alzheimer's by analyzing the brains of mice that had been subject to acute stress, comparing them with the brains of non-stressed mice.